Evidence map›Paper›PMID 35314549›Full record

ArticleInternal medicine (Tokyo, Japan)2022

Relationship between the Thyroid Function and Cognitive Impairment in the Elderly in Japan.

Sumiko Furuto-Kato, Atsushi Araki, Yuko Chiba, Michizou Nakamura, Mitsuyo Shintani, Takashi Kuwahara, Hajime Yamakage, Noriko Satoh-Asahara, Tetsuya Tagami

Open access · diamondAbstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Sumiko Furuto-KatoDepartment of Diabetes Mellitus and Endocrinology, Osaka Saiseikai Ibaraki Hospital, Japan.
Atsushi ArakiDepartment of Diabetes, Metabolism, and Endocrinology, Tokyo Metropolitan Geriatric Hospital, Japan.
Yuko ChibaDepartment of Diabetes, Metabolism, and Endocrinology, Tokyo Metropolitan Geriatric Hospital, Japan.
Michizou NakamuraDepartment of Neurology, National Hospital Organization Kyoto Medical Center, Japan.
Mitsuyo ShintaniDepartment of Diabetes Mellitus and Endocrinology, Osaka Saiseikai Nakatsu Hospital, Japan.
Takashi KuwaharaDepartment of Nephrology, Osaka Saiseikai Ibaraki Hospital, Japan.
Hajime YamakageClinical Research Institute for Endocrine and Metabolic Diseases, National Hospital Organization Kyoto Medical Center, Japan.
Noriko Satoh-AsaharaClinical Research Institute for Endocrine and Metabolic Diseases, National Hospital Organization Kyoto Medical Center, Japan.
Tetsuya TagamiClinical Research Institute for Endocrine and Metabolic Diseases, National Hospital Organization Kyoto Medical Center, Japan.
Kyoto Medical Center · JPSaiseikai Ibaraki Hospital · JPTokyo Metropolitan Geriatric Hospital · JPSaiseikai Nakatsu Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective The reference ranges of serum thyroid hormone levels are determined by the values of normal subjects aged 15 or 20 to 60 years old in Japan and may differ from the values in elderly patients. In addition, the relationship between the thyroid function and cognitive function remains controversial. We assessed the thyroid function of elderly subjects ≥60 years old and its impact on the cognitive function in Japanese adults. Methods We compared the thyroid function by age group and gender and investigated the effects of cognitive impairment on the thyroid function. This study was a cross-sectional, multi-institutional joint study. Patients The serum concentrations of thyroid hormones in 1,136 patients were measured; however, those taking thyroid hormones, anti-thyroid drugs, and steroid hormones were excluded. Among them, 1,016 cases in which the cognitive function was evaluated were divided into five groups according to their free thyroxine (FT4) levels. Results Excluding overt thyroid dysfunction (5.8%), the average age of the 1,070 remaining patients was 77.5 years old. The rate of cognitive impairment was lowest at FT4 levels of 1.1-1.2 ng/dL and highest at FT4 levels <0.9 ng/dL for both genders. Thyroid-stimulating hormone (TSH) levels in the elderly varied widely by age group and gender. The upper limit of the reference range of TSH for those ≥60 years old may be higher (7.7-9.2 mIU/L for men; 8.2-8.6 mIU/L for women) than the current range for those <60 years old (4.23 mIU/L). Conclusion The thyroid function seemed to be slightly higher (lower TSH and higher FT4) in the population without cognitive impairment than in those with cognitive impairment, except for men in their 90s.

Indexed as

Cognitive DysfunctionThyroxineAgedCross-Sectional StudiesFemaleHumansJapanMaleReference ValuesThyroid Function TestsThyroid HormonesThyrotropinThyroid HormonesThyrotropinThyroxineage groupscognitive impairmentelderly subjectsgenderthyroid hormone

Identifiers

PMID35314549
PMCPMC9646354
OpenAlexW4220760691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.